Behind the swag: Why dental reps play by different rules
Key Highlights
- The Physician Payments Sunshine Act requires applicable dental industry manufacturers to report payments and transfers of value to dentists.
- Company classifications—including pharmaceutical, medical device, start-up, distributor, and consumer goods—help explain differences in vendor gifting and sponsorship policies.
- Understanding parent-company ownership, FDA classifications, and federal and state disclosure requirements helps dental practices evaluate vendor offers and potential compliance risks.
Two sales reps walk into your practice in the same week. One offers to sponsor your entire team’s dinner at a CE course, cover your registration fee, and drop off a case of their newest product, free of charge. The other can offer you a $15 lunch and a pen. Both companies sell dental products. Both reps are equally friendly and equally invested in your practice. So, what explains the gap?
Generosity has nothing to do with it. The answer sits inside a federal transparency law called the Physician Payments Sunshine Act, and how each company gets classified under it. Once you understand that classification system, you stop just being curious about vendor behavior and start being able to evaluate it: what’s a real compliance risk, what’s a company simply operating inside its own rulebook, and why the same friendly rep from two different companies can hand you wildly different offers.
What is the Sunshine Act?
The Physician Payments Sunshine Act became law in 2010 as part of the Affordable Care Act, creating the CMS Open Payments program.1 Its purpose is simple: put financial relationships between industry and health-care providers in public view, so patients and regulators can see who is paying whom and how much.2
A few basics worth knowing:
Dentists are included. The law’s definition of “physician” includes Doctor of Dental Surgery and Doctor of Dental Medicine, so payments to dentists get reported the same way payments to physicians do.3 Dental hygienists aren’t “physicians” under the federal Sunshine Act itself, but some states run their own gift-disclosure laws with broader practitioner definitions, so check your state.
Almost anything of value counts. Meals, travel, speaking fees, consulting arrangements, royalties, ownership interests, and product samples can all qualify as “payments or transfers of value.”1
There are minimum thresholds. For 2026, single payments under roughly $13 don’t need to be reported, and yearly totals under about $131 per company are also excluded. But cross either line and it typically gets reported.4
The data is public. Anyone can search the CMS Open Payments database and see exactly what a given dentist received from a given company, by name.1
The whole system turns on one phrase: “applicable manufacturer,” a term defined in the statute itself, Section 6002 of the Affordable Care Act, codified at 42 U.S.C. § 1320a-7h.5 If a company meets that definition, it has to track and report. If it doesn’t, it generally doesn’t have to. That single distinction is why your two hypothetical reps are playing by completely different rules.
5 common classifications, and what they mean for you
No. 1: Pharmaceutical companies
Dental-adjacent examples: manufacturers of local anesthetics, prescription fluoride products, antibiotics, or pain management medications
Pharma companies are almost always applicable manufacturers, since their products are typically reimbursable under Medicare or Medicaid. That means comprehensive tracking of nearly every dollar spent on a provider, strict internal compliance policies (often built around the voluntary PhRMA Code on Interactions with Health Care Professionals6), and conservative gifting practices across the board. Don’t expect a pharma rep to cover an extravagant dinner. Internal policy usually caps that well before the legal threshold does.
No. 2: Medical device/dental technology companies
Examples: manufacturers of implants, CBCT imaging systems, CAD/CAM equipment, orthodontic hardware, some power toothbrush companies
This is where it gets nuanced. Classification often comes down to the FDA risk category of the device:
Class II or III devices (things requiring FDA clearance or approval, like implants or certain imaging equipment) usually put the manufacturer squarely in “applicable manufacturer” territory.7
Class I devices (lower-risk items, many basic dental instruments and disposables) are often exempt from FDA premarket requirements, and companies making only these products may fall outside Sunshine reporting entirely.7
Two device companies can look nearly identical on the marketing side and still carry very different compliance obligations, depending on what’s actually inside the box.
Scope matters, too—not just device class. A company that makes dental products exclusively is different from a larger health tech company that also builds hospital equipment, diagnostic imaging systems, or surgical devices across multiple specialties, with an oral health division sitting alongside them. These broader health tech companies tend to run some of the strictest compliance programs in the industry, because their Medicare/Medicaid exposure spans far more product lines and far more covered recipients than a dental-only manufacturer’s does. A rep from one of these larger companies may come across as more conservative—not because the dental product itself carries unusual risk, but because the parent company’s compliance policy covers its whole portfolio, hospital devices included.
No. 3: Start-ups
Examples: a two-year-old company launching a new intraoral scanner accessory or a novel whitening system
There’s no small-business carve-out in the law itself. Size doesn’t exempt a company. But many dental start-ups aren’t yet applicable manufacturers in practice, either because their product isn’t reimbursed under Medicare/Medicaid or because it hasn’t gone through an FDA premarket pathway that triggers coverage. That’s often why a start-up can hand out products, sponsor a study club dinner, or comp a course registration in ways an established device company can’t. They aren’t playing loose with the rules. They may genuinely sit outside the regulation’s scope, for now. That can change fast as a product line matures or expands.
No. 4: Distributors
Examples: a regional or national dealer that sells multiple manufacturers’ products but doesn’t make anything itself
Pure distributors are generally not applicable manufacturers, since they don’t manufacture, produce, or process the covered products themselves. That’s a major reason distributor reps often have more flexibility with meals, sponsorships, and giveaways: the federal reporting obligation frequently doesn’t touch them at all. The exception is when a distributor is commonly owned with a manufacturer or takes on manufacturing-like functions. That flexibility can disappear fast.
No. 5: Consumer goods companies
Examples: manufacturers of manual toothbrushes, cosmetic teeth-whitening kits, mouthwash, floss, or other over-the-counter oral care products sold in retail settings
Consumer goods companies generally sit outside Sunshine Act reporting altogether. Their products typically aren’t reimbursed by Medicare or Medicaid, and they don’t go through an FDA premarket device pathway, since they aren’t making therapeutic or diagnostic claims. This tends to be the most flexible category of all. A consumer oral care brand can sponsor a lunch-and-learn, hand out full-size products, or fund a study club event with far fewer restrictions than a pharma or device counterpart.
The catch is that the line between “consumer good” and “medical device” can be thin and claim dependent. The moment a company starts marketing the same type of product with a clinical or therapeutic claim, it can cross into medical device territory and take on a very different set of obligations. It’s the claim and the regulatory pathway that decide which bucket a company falls into—not the product category itself.
Now think back to those two sales reps. The one offering dinner, registration fees, and free products might represent a consumer goods company or a distributor, while the rep offering a modest lunch could work for a manufacturer with much stricter reporting obligations. From the practice’s perspective, the offers look dramatically different. Behind the scenes, however, the companies may simply be operating under different requirements.
“Not required to report” isn’t the same as “no rules”
It’s tempting to read all this and conclude that start-ups and distributors are compliance free-for-alls. They’re not. Many companies, regardless of legal obligation, voluntarily follow industry codes like the AdvaMed Code of Ethics on Interactions with Health Care Professionals,8 maintain their own internal gifting policies, or comply with state-level gift laws that can be stricter than federal ones. Sitting outside the Sunshine Act’s reporting requirement means less federal transparency obligation. It doesn’t mean an absence of ethics oversight, and it doesn’t mean anything goes.
Look at the parent company, not just the product on your shelf
Here’s what trips up a lot of practices: classification isn’t just about the specific product sitting on your counter. It’s about who ultimately owns the company behind it.
A small “start-up” brand or a regional distributor can look completely independent from the outside, but if it’s owned by or commonly controlled with a larger pharma or device manufacturer, the parent company’s applicable-manufacturer status can flow down to it. The law looks at corporate relationships, not just product lines. Here are a few ways this shows up in dentistry:
A distributor that looks like an independent dealer may be a wholly owned subsidiary of a major implant or imaging manufacturer. In that case, it inherits the parent’s reporting obligations, even if the distributor itself never designs or produces anything.
A “new” start-up brand may in fact be a private-label or spinoff line launched by an established manufacturer to test a product in the market. The packaging and sales team may feel independent, but the parent’s compliance obligations likely still apply.
A product you assume is tightly regulated might be sold under a manufacturer’s name but be manufactured and distributed through an unaffiliated third party with no ownership ties. The compliance picture ends up different than the label suggests.
Two companies can sell what looks like the exact same category of product and land in entirely different classifications. Take power toothbrushes. One company may market its device with therapeutic claims (reducing gingivitis, treating periodontal disease) that require FDA clearance as a medical device, putting it in med tech territory with reporting obligations attached. Another company can sell a nearly identical electric toothbrush purely as a consumer wellness product (no therapeutic claims, no FDA device pathway), landing it in the consumer goods category and generally outside Sunshine reporting altogether. Same shelf, same aisle, same general function, but completely different rulebook.
This is where the situation with our two reps becomes even more interesting. You might assume the rep offering the expensive dinner works for a smaller, more flexible company, while the rep offering lunch represents a major manufacturer. But appearances can be misleading. The company name on a rep’s badge doesn’t always tell you who owns the business or which compliance policies govern what that rep can offer.
The practical takeaway: don’t judge a company’s compliance obligations by the product they’re supporting your office with, the age of its brand, or the device in your hand. If you want to know whether a company’s generosity is a matter of policy or a matter of law, ask a simple question: who owns your company, or how are you classified? Ask it before assuming a start-up or distributor automatically lands in the more flexible category.
What this means for your practice
A generous offer isn’t automatically a red flag. It may simply reflect a company’s classification, not a compliance shortcut.
A stingy offer doesn’t mean the company is cheap. It may be operating under real federal reporting obligations and internal policy limits.
You can check for yourself. The CMS Open Payments database is public and searchable by provider’s name, so you can see exactly what’s been reported about your own financial relationships with industry.
When in doubt, ask. A rep should be able to explain, in plain terms, why their company can or can’t offer something. If they can’t, that’s worth noting.
The next time two sales reps make you two very different offers in the same week, you’ll know it’s not about who likes you more. It’s about which box each company checks on a federal form.
Author’s note: This article is intended for general educational purposes and does not constitute legal or compliance advice. Dental professionals with specific compliance questions should consult their practice’s legal counsel or compliance officer. CMS Open Payments thresholds and program details are updated periodically. Readers should confirm current-year figures directly at cms.gov/openpayments before relying on specific dollar amounts.
References
- Open payments data overview. Centers for Medicare & Medicaid Services. Updated July 9, 2026. https://www.cms.gov/priorities/key-initiatives/open-payments/data
- Data collection for open payments reporting entities. Centers for Medicare & Medicaid Services. Updated September 29, 2026. https://www.cms.gov/openpayments/program-participants/reporting-entities/data-collection
- Physician Payments Sunshine Act. AdvaMed. https://www.advamed.org/our-work/policy-areas/legal/physician-payments-sunshine-act/
- Understanding the financial thresholds in CMS open payments data. Qordata. https://www.qordata.com/financial-thresholds-in-cms-open-payments-data/
- Physician Payments Sunshine Act of 2009. S.301, 111th Congress, enacted as Section 6002 of the Patient Protection and Affordable Care Act (codified at 42 U.S.C. § 1320a-7h). U.S. Congress. https://www.congress.gov/bill/111th-congress/senate-bill/301/text
- Code on interactions with health care professionals. Pharmaceutical Research and Manufacturers of America (PhRMA). August 6, 2021. https://www.phrma.org/resources/code-on-interactions-with-health-care-professionals
- Classify your medical device. U.S. Food and Drug Administration. https://www.fda.gov/medical-devices/overview-device-regulation/classify-your-medical-device
- AdvaMed Code of Ethics on interactions with health care professionals. AdvaMed. October 6, 2025. https://www.advamed.org/member-center/resource-library/advamed-code-of-ethics/
About the Author
Heather McGuire, RDHHeather McGuire, RDH
Heather McGuire, RDH, is a dental industry leader whose career spans clinical practice, dental service organization leadership, and professional education. She serves as senior manager of professional education and relations at Philips Oral Healthcare, where she leads strategic initiatives supporting dental professionals across clinical and academic channels. Her work includes developing continuing education programs, strengthening partnerships with professional organizations and universities, and collaborating with clinicians and educators to ensure programs reflect real-world clinical practice. Contact her at [email protected].


